Nisa Investment Advisors’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Nisa Investment Advisors’s Portfolio GTHX Stock Details GTHX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-678	Closed	-$1.69K	–	2857
2023 Q2	$1.69K	Hold	678	–	–	﹤0.01%	2378
2023 Q1	$2K	Hold	678	–	–	﹤0.01%	2336
2022 Q4	$4K	Hold	678	–	–	﹤0.01%	2324
2022 Q3	$7K	Hold	678	–	–	﹤0.01%	2255
2022 Q2	$3K	Sell	678 -1,400	-67%	-$7.75K	﹤0.01%	2331
2022 Q1	$16K	Buy	2,078 +1,400	+206%	+$13.3K	﹤0.01%	2116
2021 Q4	$7K	Sell	678 -700	-51%	-$8.92K	﹤0.01%	2069
2021 Q3	$18	Hold	1,378	–	–	﹤0.01%	2119
2021 Q2	$30	Hold	1,378	–	–	﹤0.01%	2051
2021 Q1	$33	Hold	1,378	–	–	﹤0.01%	2061
2020 Q4	$25K	Buy	1,378 +950	+222%	+$14.2K	﹤0.01%	2094
2020 Q3	$5K	Hold	428	–	–	﹤0.01%	2201
2020 Q2	$10K	Hold	428	–	–	﹤0.01%	1928
2020 Q1	$5K	Buy	428 +160	+60%	+$2.99K	﹤0.01%	1958
2019 Q4	$7K	Sell	268 -25,000	-99%	-$585K	﹤0.01%	1901
2019 Q3	$576K	Buy	25,268 +24,768	+4,954%	+$781K	0.01%	1048
2019 Q2	$15K	Buy	500 +350	+233%	+$7.37K	﹤0.01%	1661
2019 Q1	$2K	Hold	150	–	–	﹤0.01%	1996
2018 Q4	$3K	Hold	150	–	–	﹤0.01%	1888
2018 Q3	$8K	Buy	+150	New	+$8.18K	﹤0.01%	1793

Other funds holding GTHX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Nisa Investment Advisors's GTHX Position: Q3 2023 in Review

Nisa Investment Advisors sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q3 2023, closing a stake of 678 shares — an estimated $1.69K sold.

Nisa Investment Advisors first reported a position in GTHX in Q3 2018 and held it in 20 quarters. The position peaked at $576K in Q3 2019. 72 funds tracked by Wall St. Rank hold GTHX as of Q3 2023.

Nisa Investment Advisors reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Nisa Investment Advisors sold 678 G1 Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $1.69K.
Nisa Investment Advisors first reported a position in G1 Therapeutics, Inc. Common Stock in Q3 2018 and held it in 20 quarters.
Nisa Investment Advisors's G1 Therapeutics, Inc. Common Stock position peaked at $576K in Q3 2019.
72 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Nisa Investment Advisors's 13F filing for Q3 2023, filed 2 Nov 2023.